查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2007808

先進生物材料市場預測至2034年：按材料類型、技術、應用、最終用戶和地區分類的全球分析

Advanced Biomaterials Market Forecasts to 2034 - Global Analysis By Material Type (Metallic Biomaterials, Polymeric Biomaterials, Ceramic Biomaterials, Natural Biomaterials, and Composite Biomaterials), Technology, Application, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 | 商品交期: 2-3個工作天內

價格

根據 Stratistics MRC 的數據，全球先進生物材料市場預計將在 2026 年達到 2,487 億美元，到 2034 年達到 4,900 億美元，預測期內複合年成長率為 8.0%。

先進生物材料是專為與生物系統相互作用而專門研發的醫用和保健材料。這些材料旨在增強其在人體內的性能、相容性和功能性。它們廣泛應用於醫療設備、植入、組織工程、藥物傳遞系統和再生醫學等領域。先進生物材料源自天然或合成原料，旨在促進癒合、修復受損組織或替代生物結構，同時確保其具有良好的生物相容性、耐久性，並最大限度地減少體內不良反應。

全球老化及相關退化性疾病

與老齡化相關的疾病，例如骨關節炎、心血管疾病和牙齒退化，需要關節重建、支架植入和人工植牙等外科手術。先進的生物材料，包括用於髖關節的耐磨聚乙烯和用於脊椎融合手術的生物活性陶瓷，對於老年患者這些手術的成功和長期穩定性至關重要。隨著平均壽命的延長，人們對具有更高骨整合性和耐久性的植入的需求日益成長。這些人口結構的變化要求我們持續研究能夠更真實地模擬天然組織特性並改善老年人生活品質的材料。

限制條件

原料高成本，製造流程複雜。

提取和提純原料成本高昂，後續的精密加工、3D列印和表面改質等製造流程也需要先進且昂貴的設備和嚴格的品管。這些高昂的製造成本導致最終醫療設備價格高昂，可能阻礙其在價格敏感型市場的普及，並加重醫療保健預算的負擔。對於小規模醫療設備製造商而言，生產先進生物材料所需的資本投入可能非常巨大，這可能會阻礙創新和市場准入。這種經濟壁壘可能會減緩下一代植入技術的應用。

機會

再生醫學和組織工程的擴展

快速發展的再生醫學領域為先進生物材料帶來了變革性的機會。目前，人們正從永久性植入轉向支持人體自身癒合過程的暫時性生物可吸收支架。諸如可生物分解聚合物、生物活性玻璃和水凝膠等生物材料正被開發用於建造支架，以促進細胞增殖和組織再生，其應用範圍廣泛，涵蓋創傷治療到器官修復。隨著複雜組織和器官工程研究的不斷深入，對能夠模擬細胞外基質並傳遞生物訊號的材料的需求將激增。這為不僅提供結構支撐而且能夠積極參與癒合過程的材料開闢了新的可能性。

有害生物反應和植入失效的風險

即使經過嚴格的測試，長期生物相容性問題的風險仍然是一個重大威脅。植入材料可能引起慢性發炎、纖維囊形成或過敏反應，進而導致植入失敗或需要再次手術。金屬植入的腐蝕以及釋放特定材料成分的聚合物劣化也是持續存在的挑戰。因材料缺陷導致的大規模產品召回會損害公眾信任，並導致監管機構加強審查。為了應對這一威脅，持續投資於表面改質技術以及開發具有更好血液相容性和組織整合性的下一代材料對於降低生物風險和確保患者安全至關重要。

新冠疫情的影響

新冠疫情對先進生物材料市場產生了雙重影響。起初，全球部分手術的取消導致植入式醫療設備需求急劇下降，直接衝擊了生物材料生產商。原料和特殊零件的供應鏈中斷，生產也因此延誤。然而，這場危機凸顯了創新的重要性。用於抗病毒塗層和先進創傷護理的生物材料研究加速推進。隨著後疫情時代對韌性醫療基礎設施的日益重視，人們對本地化生產和研發的興趣再次高漲，更加關注用於快速醫療響應解決方案的材料以及能夠縮短住院時間的技術。

在預測期內，聚合物生物材料領域預計將佔據最大的市場佔有率。

由於其柔軟性、輕質和可調節的分解速率，預計在預測期內，聚合物基生物材料將佔據最大的市場佔有率。這些材料應用廣泛，涵蓋藥物傳遞系統、外科縫線以及耐用植入（例如用於脊椎融合手術的PEEK材料）等許多領域。該領域的成長主要得益於用於組織工程和可吸收醫療設備的生物分解聚合物的創新。這些材料可透過化學修飾以適應特定的生物相互作用，使其成為現代醫療設備中不可或缺的組成部分。隨著抗菌塗層和刺激響應材料的開發，其臨床效用正在擴大。

在預測期內，製藥和生技公司板塊預計將呈現最高的複合年成長率。

在預測期內，製藥和生物技術公司板塊預計將呈現最高的成長率，這主要得益於廣泛應用於藥物製劑和遞送的先進生物材料。該板塊需要高純度聚合物來製造緩釋劑、微球和植入，從而實現治療藥物的可控靶向遞送。生物製藥和個人化醫療的興起推動了該板塊的成長，而這些領域需要先進的遞送方法來提高療效和患者依從性。

市佔率最大的地區：

在整個預測期內，北美預計將保持最大的市場佔有率，這主要得益於其先進的醫療基礎設施、高昂的醫療費用支出以及眾多大型醫療設備和生物材料公司的存在。該地區是技術創新中心，在再生醫學和下一代植入擁有大量的研究經費。大量的關節重建和心血管手術，加上對先進手術的有利報銷政策，確保了強勁的市場需求。

複合年成長率最高的地區：

在預測期內，亞太地區預計將呈現最高的複合年成長率，這主要得益於龐大的患者群體、新興中產階級的崛起及其醫療服務可及性的提高，以及各國政府對醫療基礎設施現代化的巨額投資。中國、印度和日本等國的醫療設備製造業正蓬勃發展，日益成為重要的臨床研究中心。慢性病盛行率的上升和人口老化的加劇也推動了對植入的需求。

免費客製化服務：

所有購買此報告的客戶均可享受以下免費自訂選項之一：

  • 企業概況
    • 對其他市場參與者（最多 3 家公司）進行全面分析
    • 對主要企業進行SWOT分析（最多3家公司）
  • 區域細分
    • 應客戶要求，我們提供主要國家和地區的市場估算和預測，以及複合年成長率（註：需進行可行性檢查）。
  • 競爭性標竿分析
    • 根據產品系列、地理覆蓋範圍和策略聯盟對主要企業進行基準分析。

目錄

第1章執行摘要

  • 市場概覽及主要亮點
  • 促進因素、挑戰與機遇
  • 競爭格局概述
  • 戰略洞察與建議

第2章：研究框架

  • 研究目標和範圍
  • 相關人員分析
  • 研究假設和限制
  • 調查方法

第3章 市場動態與趨勢分析

  • 市場定義與結構
  • 主要市場促進因素
  • 市場限制與挑戰
  • 投資成長機會和重點領域
  • 產業威脅與風險評估
  • 技術與創新展望
  • 新興市場/高成長市場
  • 監管和政策環境
  • 新冠疫情的影響及復甦前景

第4章：競爭環境與策略評估

  • 波特五力分析
    • 供應商的議價能力
    • 買方的議價能力
    • 替代品的威脅
    • 新進入者的威脅
    • 競爭公司之間的競爭
  • 主要企業市佔率分析
  • 產品基準評效和效能比較

第5章：全球先進生物材料市場：依材料類型分類

  • 金屬生物材料
    • 不銹鋼
    • 鈦及鈦合金
    • 鈷鉻合金
    • 鎂合金
  • 以聚合物為基礎的生物材料
    • 聚甲基丙烯酸甲酯（PMMA）
    • 聚乙烯
    • 聚氯乙烯（PVC）
    • 矽橡膠
    • 聚醚醚酮（PEEK）
    • 可生物分解聚合物
  • 陶瓷生物材料
    • 氧化鋁
    • 氧化鋯
    • 磷酸鈣
    • 生物活性玻璃
  • 天然生物材料
    • 膠原蛋白
    • 玻尿酸
    • 明膠
    • 幾丁聚醣
    • 海藻酸鹽
  • 複合生物材料

第6章 全球先進生物材料市場：依技術分類

  • 3D列印和生物列印
  • 表面改質技術
  • 基於奈米技術的生物材料
  • 靜電紡絲技術

第7章 全球先進生物材料市場：依應用領域分類

  • 整形外科應用
    • 關節重建手術
    • 骨移植材料
    • 脊椎移植
  • 心血管應用
    • 支架
    • 心臟瓣膜
    • 血管移植
  • 牙科用途
    • 植入
    • 骨替代材料
    • 牙科修補
  • 眼科
  • 神經病學
  • 整形和重組外科
  • 組織工程與再生醫學
  • 創傷治療

第8章 全球先進生物材料市場：依最終用戶分類

  • 醫院和診所
  • 門診手術中心
  • 研究和學術機構
  • 製藥和生物技術公司
  • 醫療設備製造商

第9章 全球先進生物材料市場：依地區分類

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 荷蘭
    • 比利時
    • 瑞典
    • 瑞士
    • 波蘭
    • 其他歐洲國家
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 泰國
    • 馬來西亞
    • 新加坡
    • 越南
    • 其他亞太國家
  • 南美洲
    • 巴西
    • 阿根廷
    • 哥倫比亞
    • 智利
    • 秘魯
    • 其他南美國家
  • 世界其他地區（RoW）
    • 中東
      • 沙烏地阿拉伯
      • 阿拉伯聯合大公國
      • 卡達
      • 以色列
      • 其他中東國家
    • 非洲
      • 南非
      • 埃及
      • 摩洛哥
      • 其他非洲國家

第10章 戰略市場資訊

  • 工業價值網路和供應鏈評估
  • 空白區域和機會地圖
  • 產品演進與市場生命週期分析
  • 通路、經銷商和打入市場策略的評估

第11章 產業趨勢與策略舉措

  • 併購
  • 夥伴關係、聯盟和合資企業
  • 新產品發布和認證
  • 擴大生產能力和投資
  • 其他策略舉措

第12章：公司簡介

  • Medtronic plc
  • Dentsply Sirona Inc.
  • Johnson & Johnson
  • Invibio Ltd.
  • Stryker Corporation
  • GELITA AG
  • Zimmer Biomet Holdings, Inc.
  • CoorsTek Inc.
  • Evonik Industries AG
  • CeramTec GmbH
  • BASF SE
  • Berkeley Advanced Biomaterials, Inc.
  • Corbion NV
  • Carpenter Technology Corporation
  • Celanese Corporation
Product Code: SMRC34680

According to Stratistics MRC, the Global Advanced Biomaterials Market is accounted for $248.7 billion in 2026 and is expected to reach $490.0 billion by 2034, growing at a CAGR of 8.0% during the forecast period. Advanced biomaterials are specially engineered materials designed to interact with biological systems for medical and healthcare applications. These materials are developed to enhance performance, compatibility, and functionality within the human body. They are widely used in medical devices, implants, tissue engineering, drug delivery systems, and regenerative medicine. Advanced biomaterials can be derived from natural or synthetic sources and are designed to support healing, repair damaged tissues, or replace biological structures while ensuring biocompatibility, durability, and minimal adverse reactions within the body.

Market Dynamics:

Driver:

Growing global geriatric population and associated degenerative diseases

Age-related conditions such as osteoarthritis, cardiovascular diseases, and dental degeneration necessitate surgical interventions like joint replacements, stents, and dental implants. Advanced biomaterials, including wear-resistant polyethylene for hips and bioactive ceramics for spinal fusion, are critical for the success and longevity of these procedures in older patients. As life expectancy rises, the demand for implants that offer enhanced osseointegration and durability grows. This demographic shift compels ongoing research into materials that can better mimic natural tissue properties and ensure a higher quality of life for the aging population.

Restraint

High cost of raw materials and complex manufacturing processes

Raw material extraction and purification are expensive, and subsequent manufacturing processes like precision machining, 3D printing, and surface modification require sophisticated, costly equipment and stringent quality controls. These high production costs translate to expensive final medical devices, which can limit accessibility in price-sensitive markets and strain healthcare budgets. For smaller medical device companies, the capital investment required for advanced biomaterial fabrication can be prohibitive, hindering innovation and market entry. This economic barrier can slow the widespread adoption of next-generation implant technologies.

Opportunity

Expansion of regenerative medicine and tissue engineering

The burgeoning field of regenerative medicine presents a transformative opportunity for advanced biomaterials. There is a growing shift from permanent implants to temporary, bioresorbable scaffolds that support the body's own healing process. Biomaterials like biodegradable polymers, bioactive glasses, and hydrogels are being engineered to create scaffolds that encourage cell growth and tissue regeneration for applications ranging from wound healing to organ repair. As research progresses towards complex tissue and organ engineering, the demand for materials that can mimic the extracellular matrix and deliver biological cues will skyrocket. This opens new frontiers for materials that actively participate in healing, rather than just providing structural support.

Threat:

Risk of adverse biological reactions and implant failures

Despite rigorous testing, the risk of long-term biocompatibility issues remains a significant threat. Implanted materials can sometimes trigger chronic inflammation, fibrous encapsulation, or allergic reactions, leading to implant failure and the need for revision surgeries. Issues such as corrosion of metallic implants or degradation of polymers releasing byproducts pose ongoing challenges. High-profile product recalls due to material shortcomings can erode public trust and lead to stricter regulatory scrutiny. This threat necessitates continuous investment in surface modification technologies and the development of next-generation materials with improved hemocompatibility and tissue integration to mitigate biological risks and ensure patient safety.

Covid-19 Impact

The COVID-19 pandemic had a dual impact on the advanced biomaterials market. Initially, the suspension of elective surgeries worldwide caused a sharp decline in demand for implantable devices, directly affecting biomaterial producers. Supply chains for raw materials and specialized components were disrupted, delaying production. However, the crisis also underscored the importance of innovation. It accelerated research into biomaterials for antiviral coatings and advanced wound care. The focus on resilient healthcare infrastructure post-pandemic has renewed interest in local manufacturing and R&D, with a greater emphasis on materials for rapid-response medical solutions and technologies that reduce hospital stay durations.

The polymeric biomaterials segment is expected to be the largest during the forecast period

The polymeric biomaterials segment is expected to account for the largest market share during the forecast period, due to their flexibility, lightweight nature, and tunable degradation rates. They are extensively used in applications ranging from drug delivery systems and surgical sutures to durable implants like PEEK for spinal fusion. The segment is driven by innovations in biodegradable polymers for tissue engineering and resorbable devices. Their ability to be chemically modified for specific biological interactions makes them indispensable for modern medical devices, with ongoing development in antimicrobial coatings and stimuli-responsive materials expanding their clinical utility.

The pharmaceutical & biotechnology companies segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the pharmaceutical & biotechnology companies segment is predicted to witness the highest growth rate, driven by advanced biomaterials, utilizing them extensively in drug formulation and delivery. They demand high-purity polymers for creating depots, microspheres, and implants that enable controlled, targeted release of therapeutics. This segment's growth is propelled by the rise of biologics and personalized medicine, which require sophisticated delivery vehicles to improve efficacy and patient compliance.

Region with largest share:

During the forecast period, the North America region is expected to hold the largest market share, driven by its advanced healthcare infrastructure, high healthcare expenditure, and the presence of major medical device and biomaterial companies. The region is a hub for technological innovation, with significant research funding directed towards regenerative medicine and next-generation implants. High surgical volumes for joint replacements and cardiovascular procedures, coupled with favorable reimbursement policies for advanced procedures, ensure robust market demand.

Region with highest CAGR:

Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR, propelled by large patient pools, a rising middle class with greater access to healthcare, and significant government investments in modernizing healthcare infrastructure. Countries like China, India, and Japan are seeing a surge in medical device manufacturing and are increasingly becoming hubs for clinical research. The growing prevalence of chronic diseases and a rapidly aging population are driving demand for implants.

Key players in the market

Some of the key players in Advanced Biomaterials Market include Medtronic plc, Dentsply Sirona Inc., Johnson & Johnson, Invibio Ltd., Stryker Corporation, GELITA AG, Zimmer Biomet Holdings, Inc., CoorsTek Inc., Evonik Industries AG, CeramTec GmbH, BASF SE, Berkeley Advanced Biomaterials, Inc., Corbion N.V., Carpenter Technology Corporation, and Celanese Corporation.

Key Developments:

In November 2025, BASF announced the expansion of its Alkyl Polyglucosides (APGs) footprint in Asia with a new plant at the Bangpakong site in Thailand. The enhancement is a strategic response to strengthen its position in growth geography and serve customers with greater agility and more flexibility from a robust regional network.

In September 2024, Evonik launched a new high-performance PEEK filament for medical 3D printing, specifically designed for patient-specific, load-bearing implants. This new material offers enhanced radiolucency and mechanical strength, streamlining the production of customized spinal and trauma devices.

Material Types Covered:

  • Metallic Biomaterials
  • Polymeric Biomaterials
  • Ceramic Biomaterials
  • Natural Biomaterials
  • Composite Biomaterials

Technologies Covered:

  • 3D Printing & Bioprinting
  • Surface Modification Technologies
  • Nanotechnology-based Biomaterials
  • Electrospinning Techniques

Applications Covered:

  • Orthopedic Applications
  • Cardiovascular Applications
  • Dental Applications
  • Ophthalmology
  • Neurology
  • Plastic & Reconstructive Surgery
  • Tissue Engineering & Regenerative Medicine
  • Wound Healing

End Users Covered:

  • Hospitals & Clinics
  • Ambulatory Surgical Centers
  • Research & Academic Institutes
  • Pharmaceutical & Biotechnology Companies
  • Medical Device Manufacturers

Regions Covered:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • United Kingdom
    • Germany
    • France
    • Italy
    • Spain
    • Netherlands
    • Belgium
    • Sweden
    • Switzerland
    • Poland
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Thailand
    • Malaysia
    • Singapore
    • Vietnam
    • Rest of Asia Pacific
  • South America
    • Brazil
    • Argentina
    • Colombia
    • Chile
    • Peru
    • Rest of South America
  • Rest of the World (RoW)
    • Middle East
  • Saudi Arabia
  • United Arab Emirates
  • Qatar
  • Israel
  • Rest of Middle East
    • Africa
  • South Africa
  • Egypt
  • Morocco
  • Rest of Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2023, 2024, 2025, 2026, 2027, 2028, 2030, 2032 and 2034
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

  • 1.1 Market Snapshot and Key Highlights
  • 1.2 Growth Drivers, Challenges, and Opportunities
  • 1.3 Competitive Landscape Overview
  • 1.4 Strategic Insights and Recommendations

2 Research Framework

  • 2.1 Study Objectives and Scope
  • 2.2 Stakeholder Analysis
  • 2.3 Research Assumptions and Limitations
  • 2.4 Research Methodology
    • 2.4.1 Data Collection (Primary and Secondary)
    • 2.4.2 Data Modeling and Estimation Techniques
    • 2.4.3 Data Validation and Triangulation
    • 2.4.4 Analytical and Forecasting Approach

3 Market Dynamics and Trend Analysis

  • 3.1 Market Definition and Structure
  • 3.2 Key Market Drivers
  • 3.3 Market Restraints and Challenges
  • 3.4 Growth Opportunities and Investment Hotspots
  • 3.5 Industry Threats and Risk Assessment
  • 3.6 Technology and Innovation Landscape
  • 3.7 Emerging and High-Growth Markets
  • 3.8 Regulatory and Policy Environment
  • 3.9 Impact of COVID-19 and Recovery Outlook

4 Competitive and Strategic Assessment

  • 4.1 Porter's Five Forces Analysis
    • 4.1.1 Supplier Bargaining Power
    • 4.1.2 Buyer Bargaining Power
    • 4.1.3 Threat of Substitutes
    • 4.1.4 Threat of New Entrants
    • 4.1.5 Competitive Rivalry
  • 4.2 Market Share Analysis of Key Players
  • 4.3 Product Benchmarking and Performance Comparison

5 Global Advanced Biomaterials Market, By Material Type

  • 5.1 Metallic Biomaterials
    • 5.1.1 Stainless Steel
    • 5.1.2 Titanium & Titanium Alloys
    • 5.1.3 Cobalt-Chromium Alloys
    • 5.1.4 Magnesium Alloys
  • 5.2 Polymeric Biomaterials
    • 5.2.1 Polymethyl Methacrylate (PMMA)
    • 5.2.2 Polyethylene
    • 5.2.3 Polyvinyl Chloride (PVC)
    • 5.2.4 Silicone Rubber
    • 5.2.5 Polyether Ether Ketone (PEEK)
    • 5.2.6 Biodegradable Polymers
  • 5.3 Ceramic Biomaterials
    • 5.3.1 Aluminum Oxide
    • 5.3.2 Zirconia
    • 5.3.3 Calcium Phosphate
    • 5.3.4 Bioactive Glass
  • 5.4 Natural Biomaterials
    • 5.4.1 Collagen
    • 5.4.2 Hyaluronic Acid
    • 5.4.3 Gelatin
    • 5.4.4 Chitosan
    • 5.4.5 Alginate
  • 5.5 Composite Biomaterials

6 Global Advanced Biomaterials Market, By Technology

  • 6.1 3D Printing & Bioprinting
  • 6.2 Surface Modification Technologies
  • 6.3 Nanotechnology-based Biomaterials
  • 6.4 Electrospinning Techniques

7 Global Advanced Biomaterials Market, By Application

  • 7.1 Orthopedic Applications
    • 7.1.1 Joint Replacement
    • 7.1.2 Bone Grafts
    • 7.1.3 Spinal Implants
  • 7.2 Cardiovascular Applications
    • 7.2.1 Stents
    • 7.2.2 Heart Valves
    • 7.2.3 Vascular Grafts
  • 7.3 Dental Applications
    • 7.3.1 Dental Implants
    • 7.3.2 Bone Substitutes
    • 7.3.3 Dental Prosthetics
  • 7.4 Ophthalmology
  • 7.5 Neurology
  • 7.6 Plastic & Reconstructive Surgery
  • 7.7 Tissue Engineering & Regenerative Medicine
  • 7.8 Wound Healing

8 Global Advanced Biomaterials Market, By End User

  • 8.1 Hospitals & Clinics
  • 8.2 Ambulatory Surgical Centers
  • 8.3 Research & Academic Institutes
  • 8.4 Pharmaceutical & Biotechnology Companies
  • 8.5 Medical Device Manufacturers

9 Global Advanced Biomaterials Market, By Geography

  • 9.1 North America
    • 9.1.1 United States
    • 9.1.2 Canada
    • 9.1.3 Mexico
  • 9.2 Europe
    • 9.2.1 United Kingdom
    • 9.2.2 Germany
    • 9.2.3 France
    • 9.2.4 Italy
    • 9.2.5 Spain
    • 9.2.6 Netherlands
    • 9.2.7 Belgium
    • 9.2.8 Sweden
    • 9.2.9 Switzerland
    • 9.2.10 Poland
    • 9.2.11 Rest of Europe
  • 9.3 Asia Pacific
    • 9.3.1 China
    • 9.3.2 Japan
    • 9.3.3 India
    • 9.3.4 South Korea
    • 9.3.5 Australia
    • 9.3.6 Indonesia
    • 9.3.7 Thailand
    • 9.3.8 Malaysia
    • 9.3.9 Singapore
    • 9.3.10 Vietnam
    • 9.3.11 Rest of Asia Pacific
  • 9.4 South America
    • 9.4.1 Brazil
    • 9.4.2 Argentina
    • 9.4.3 Colombia
    • 9.4.4 Chile
    • 9.4.5 Peru
    • 9.4.6 Rest of South America
  • 9.5 Rest of the World (RoW)
    • 9.5.1 Middle East
      • 9.5.1.1 Saudi Arabia
      • 9.5.1.2 United Arab Emirates
      • 9.5.1.3 Qatar
      • 9.5.1.4 Israel
      • 9.5.1.5 Rest of Middle East
    • 9.5.2 Africa
      • 9.5.2.1 South Africa
      • 9.5.2.2 Egypt
      • 9.5.2.3 Morocco
      • 9.5.2.4 Rest of Africa

10 Strategic Market Intelligence

  • 10.1 Industry Value Network and Supply Chain Assessment
  • 10.2 White-Space and Opportunity Mapping
  • 10.3 Product Evolution and Market Life Cycle Analysis
  • 10.4 Channel, Distributor, and Go-to-Market Assessment

11 Industry Developments and Strategic Initiatives

  • 11.1 Mergers and Acquisitions
  • 11.2 Partnerships, Alliances, and Joint Ventures
  • 11.3 New Product Launches and Certifications
  • 11.4 Capacity Expansion and Investments
  • 11.5 Other Strategic Initiatives

12 Company Profiles

  • 12.1 Medtronic plc
  • 12.2 Dentsply Sirona Inc.
  • 12.3 Johnson & Johnson
  • 12.4 Invibio Ltd.
  • 12.5 Stryker Corporation
  • 12.6 GELITA AG
  • 12.7 Zimmer Biomet Holdings, Inc.
  • 12.8 CoorsTek Inc.
  • 12.9 Evonik Industries AG
  • 12.10 CeramTec GmbH
  • 12.11 BASF SE
  • 12.12 Berkeley Advanced Biomaterials, Inc.
  • 12.13 Corbion N.V.
  • 12.14 Carpenter Technology Corporation
  • 12.15 Celanese Corporation

List of Tables

  • Table 1 Global Advanced Biomaterials Market Outlook, By Region (2023-2034) ($MN)
  • Table 2 Global Advanced Biomaterials Market Outlook, By Material Type (2023-2034) ($MN)
  • Table 3 Global Advanced Biomaterials Market Outlook, By Metallic Biomaterials (2023-2034) ($MN)
  • Table 4 Global Advanced Biomaterials Market Outlook, By Stainless Steel (2023-2034) ($MN)
  • Table 5 Global Advanced Biomaterials Market Outlook, By Titanium & Titanium Alloys (2023-2034) ($MN)
  • Table 6 Global Advanced Biomaterials Market Outlook, By Cobalt-Chromium Alloys (2023-2034) ($MN)
  • Table 7 Global Advanced Biomaterials Market Outlook, By Magnesium Alloys (2023-2034) ($MN)
  • Table 8 Global Advanced Biomaterials Market Outlook, By Polymeric Biomaterials (2023-2034) ($MN)
  • Table 9 Global Advanced Biomaterials Market Outlook, By Polymethyl Methacrylate (PMMA) (2023-2034) ($MN)
  • Table 10 Global Advanced Biomaterials Market Outlook, By Polyethylene (2023-2034) ($MN)
  • Table 11 Global Advanced Biomaterials Market Outlook, By Polyvinyl Chloride (PVC) (2023-2034) ($MN)
  • Table 12 Global Advanced Biomaterials Market Outlook, By Silicone Rubber (2023-2034) ($MN)
  • Table 13 Global Advanced Biomaterials Market Outlook, By Polyether Ether Ketone (PEEK) (2023-2034) ($MN)
  • Table 14 Global Advanced Biomaterials Market Outlook, By Biodegradable Polymers (2023-2034) ($MN)
  • Table 15 Global Advanced Biomaterials Market Outlook, By Ceramic Biomaterials (2023-2034) ($MN)
  • Table 16 Global Advanced Biomaterials Market Outlook, By Aluminum Oxide (2023-2034) ($MN)
  • Table 17 Global Advanced Biomaterials Market Outlook, By Zirconia (2023-2034) ($MN)
  • Table 18 Global Advanced Biomaterials Market Outlook, By Calcium Phosphate (2023-2034) ($MN)
  • Table 19 Global Advanced Biomaterials Market Outlook, By Bioactive Glass (2023-2034) ($MN)
  • Table 20 Global Advanced Biomaterials Market Outlook, By Natural Biomaterials (2023-2034) ($MN)
  • Table 21 Global Advanced Biomaterials Market Outlook, By Collagen (2023-2034) ($MN)
  • Table 22 Global Advanced Biomaterials Market Outlook, By Hyaluronic Acid (2023-2034) ($MN)
  • Table 23 Global Advanced Biomaterials Market Outlook, By Gelatin (2023-2034) ($MN)
  • Table 24 Global Advanced Biomaterials Market Outlook, By Chitosan (2023-2034) ($MN)
  • Table 25 Global Advanced Biomaterials Market Outlook, By Alginate (2023-2034) ($MN)
  • Table 26 Global Advanced Biomaterials Market Outlook, By Composite Biomaterials (2023-2034) ($MN)
  • Table 27 Global Advanced Biomaterials Market Outlook, By Technology (2023-2034) ($MN)
  • Table 28 Global Advanced Biomaterials Market Outlook, By 3D Printing & Bioprinting (2023-2034) ($MN)
  • Table 29 Global Advanced Biomaterials Market Outlook, By Surface Modification Technologies (2023-2034) ($MN)
  • Table 30 Global Advanced Biomaterials Market Outlook, By Nanotechnology-based Biomaterials (2023-2034) ($MN)
  • Table 31 Global Advanced Biomaterials Market Outlook, By Electrospinning Techniques (2023-2034) ($MN)
  • Table 32 Global Advanced Biomaterials Market Outlook, By Application (2023-2034) ($MN)
  • Table 33 Global Advanced Biomaterials Market Outlook, By Orthopedic Applications (2023-2034) ($MN)
  • Table 34 Global Advanced Biomaterials Market Outlook, By Joint Replacement (2023-2034) ($MN)
  • Table 35 Global Advanced Biomaterials Market Outlook, By Bone Grafts (2023-2034) ($MN)
  • Table 36 Global Advanced Biomaterials Market Outlook, By Spinal Implants (2023-2034) ($MN)
  • Table 37 Global Advanced Biomaterials Market Outlook, By Cardiovascular Applications (2023-2034) ($MN)
  • Table 38 Global Advanced Biomaterials Market Outlook, By Stents (2023-2034) ($MN)
  • Table 39 Global Advanced Biomaterials Market Outlook, By Heart Valves (2023-2034) ($MN)
  • Table 40 Global Advanced Biomaterials Market Outlook, By Vascular Grafts (2023-2034) ($MN)
  • Table 41 Global Advanced Biomaterials Market Outlook, By Dental Applications (2023-2034) ($MN)
  • Table 42 Global Advanced Biomaterials Market Outlook, By Dental Implants (2023-2034) ($MN)
  • Table 43 Global Advanced Biomaterials Market Outlook, By Bone Substitutes (2023-2034) ($MN)
  • Table 44 Global Advanced Biomaterials Market Outlook, By Dental Prosthetics (2023-2034) ($MN)
  • Table 45 Global Advanced Biomaterials Market Outlook, By Ophthalmology (2023-2034) ($MN)
  • Table 46 Global Advanced Biomaterials Market Outlook, By Neurology (2023-2034) ($MN)
  • Table 47 Global Advanced Biomaterials Market Outlook, By Plastic & Reconstructive Surgery (2023-2034) ($MN)
  • Table 48 Global Advanced Biomaterials Market Outlook, By Tissue Engineering & Regenerative Medicine (2023-2034) ($MN)
  • Table 49 Global Advanced Biomaterials Market Outlook, By Wound Healing (2023-2034) ($MN)
  • Table 50 Global Advanced Biomaterials Market Outlook, By End User (2023-2034) ($MN)
  • Table 51 Global Advanced Biomaterials Market Outlook, By Hospitals & Clinics (2023-2034) ($MN)
  • Table 52 Global Advanced Biomaterials Market Outlook, By Ambulatory Surgical Centers (2023-2034) ($MN)
  • Table 53 Global Advanced Biomaterials Market Outlook, By Research & Academic Institutes (2023-2034) ($MN)
  • Table 54 Global Advanced Biomaterials Market Outlook, By Pharmaceutical & Biotechnology Companies (2023-2034) ($MN)
  • Table 55 Global Advanced Biomaterials Market Outlook, By Medical Device Manufacturers (2023-2034) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Rest of the World (RoW) are also represented in the same manner as above.